Lupus Research Alliance News
ACR Released a Summary of the 2024 ACR Guideline for the Screening, Treatment, and Management of Lupus Nephritis

November 18, 2024 — The American College of Rheumatology (ACR) released a summary of the 2024 ACR Guideline for the Screening, Treatment, and Management of Lupus Nephritis during ACR Convergence 2024. “This is the College’s first lupus nephritis guideline since 2012 and provides evidence-based, expert guidance for the condition in adults and children.” Lupus Therapeutics, […] READ MORE

Lupus Research Alliance Announces Inaugural Recipients of Translational Bridge Award

NEW YORK, NY, November 6, 2024 — The Lupus Research Alliance (LRA) is excited to announce the first-ever recipients of the Translational Bridge Award (TBA), established this year to accelerate the translation of groundbreaking research into potential treatments and diagnostics for lupus. The award aims to propel high-potential projects from LRA-funded foundational discoveries with strong […] READ MORE

Lupus ABC Committee Takes on Lupus Patient Reported Outcomes

October 16, 2024 — As part of our researcher interview series, we are featuring 3 Questions with Patricia Katz, PhD, Professor of Medicine and Health Policy at the University of California, San Francisco. Dr. Katz chairs the Lupus Accelerating Breakthroughs Consortium (Lupus ABC) Planning Committee on Patient Reported Outcomes (PRO) and is chairing a meeting on […] READ MORE

Facing Lupus with a Positive Perspective

September 26, 2024 — Radiating optimism despite living with lupus for most of her young life, this month’s Community Inspiration,17-year old Miah Andrade, has a powerful message to share during Hispanic Heritage Month: “Too many people don’t know what lupus is or that Hispanics are at greater risk for the disease than those in other […] READ MORE

Gazyva® Shows Positive Results in Phase 3 Lupus Nephritis Trial

NEW YORK, NY, September 25, 2024 — The Lupus Research Alliance (LRA) and clinical research affiliate Lupus Therapeutics (LT) are excited to share positive news of the Phase 3 REGENCY clinical trial showing benefits of Gazyva® (obinutuzumab) in treating people with active lupus nephritis (inflammation of the kidney associated with lupus). In development as a potential treatment […] READ MORE

LRA Congratulates Dr. James Chen for Prestigious Lasker Award Recognizing Breakthrough Discovery of DNA Sensing Enzyme, cGAS  

September 24, 2024 — The Lupus Research Alliance (LRA) proudly congratulates Dr. Zhijian “James” Chen on receiving the 2024 Albert Lasker Basic Medical Research Award for his revolutionary discovery of cGAS, a molecule that senses self and foreign DNA, activating the immune system. While cGAS is essential for detecting foreign DNA from pathogens like viruses […] READ MORE

Together, ManyOne Can make a difference!